Transcranial magneticstimulation for enhancing recovery of function after acute stroke.(TRYST) - TRYST

Investigator initiated0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. First episode of acute hemispheric stroke (infarct or bleed) as established on neuroimaging
•2. Age 18 - 80 years
•3. Day 3 â?? 15 from onset of stroke symptoms,
•4. NIH arm motor score >1
•5. Stable GCS greater than or equal to 8 and off ventilator for 48 hours

•1 Patients with major cognitive deficits/spasticity / contracture/limb deformities interfering with study participation.
•2. Epilepsy, psychosis, delirium.
•3. Patients who received Intravenous or Intra-arterial tissue plasminogen activator or thrombectomy
•4. Concomitant acute Myocardial Infarction, pulmonary embolism or Deep Venous Thrombosis
•5. Hemodynamic instability
•6. Major cardiac, renal, hepatic or pulmonary dysfunction
•7. Uncontrolled sepsis
•8. Trauma-orthopedic injury that limits the range of motion of the upper limb
•9. Contraindications to TMS like intracranial metallic implants, cardiac implants, pacemakers
•10. Pregnancy or likely to become pregnant during the study period.
•11. Patients with stroke associated with CNS infections, HIV, malignancy, haemopoetic disorders
•12. Premorbid MRS score- greater than 2
•13. Not willing to consent

发起方

Investigator initiated